Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Benitec Biopharma Ltd ADR (Sponsored) (New) BTEBY

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:BTEBY)

Benitec Biopharma advances OPMD orphan disease program

PR Newswire August 8, 2017

Technical Reports on Biotech Equities -- BioDelivery Sciences, BioLine Rx, Benitec Biopharma, and Soligenix

PR Newswire August 1, 2017

Biotech Stock Performance Review -- Cellect Biotechnology, BioDelivery Sciences, BioLine Rx, and Benitec Biopharma

PR Newswire June 6, 2017

How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

PR Newswire April 26, 2017

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  April 5, 2017

Mid-Day Market Update: Conn's Surges On Earnings Beat; Seadrill Shares Slide

Benzinga.com  April 4, 2017

Mid-Morning Market Update: Markets Edge Lower; Acuity Brands Misses Q2 Estimates

Benzinga.com  April 4, 2017

Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications

PR Newswire April 4, 2017

Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

PR Newswire March 24, 2017

Opinion & Analysis (GREY:BTEBY)

The ASX: investing in an emerging biotech frontier

The Life Sciences Report August 10, 2016

Bullboard Posts (GREY:BTEBY)